Combination of Androgen Deprivation Therapy with Radical Local Therapy Versus Androgen Deprivation Therapy Alone for Newly Diagnosed Oligometastatic Prostate Cancer: A Phase II Randomized Controlled Trial-Reference-Cited by-同舟云学术

Combination of Androgen Deprivation Therapy with Radical Local Therapy Versus Androgen Deprivation Therapy Alone for Newly Diagnosed Oligometastatic Prostate Cancer: A Phase II Randomized Controlled Trial

Published:2022-10 Issue:5 Volume:5 Page:519-525
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Dai Bo,Zhang Sheng,Wan Fang-Ning,Wang Hong-Kai,Zhang Jun-Yu,Wang Qi-Feng,Kong Yun-Yi,Ma Xue-Jun,Mo Miao,Zhu Yao,Qin Xiao-Jian,Lin Guo-Wen,Ye Ding-Wei

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference15 articles.

1. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study;Culp;Eur Urol,2014

2. Identifying optimal candidates for local treatment of the primary tumor among patients diagnosed with metastatic prostate cancer: a SEER-based study;Fossati;Eur Urol,2015

3. Role of radical prostatectomy in metastatic prostate cancer: data from the Munich Cancer Registry;Gratzke;Eur Urol,2014

4. Improved survival with prostate radiation in addition to androgen deprivation therapy for men with newly diagnosed metastatic prostate cancer;Rusthoven;J Clin Oncol,2016

5. Radical prostatectomy or external beam radiation therapy vs no local therapy for survival benefit in metastatic prostate cancer: a SEER-Medicare analysis;Satkunasivam;J Urol,2015

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety evaluation of androgen deprivation therapy-based combinations for metastatic castration-sensitive prostate cancer: a systematic review and network meta-analysis;British Journal of Cancer;2024-09-02

2. Local treatment benefits patients with oligometastatic prostate cancer: A systematic review and meta‐analysis;International Journal of Urology;2024-07-16

3. Patients’ Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer: The IP5-MATTER Study;European Urology Oncology;2024-07

4. The prognostic significance of additional localized treatment to primary lesion in patients undergoing hormone therapy for metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis;PLOS ONE;2024-06-10

5. Current issues and management consensus of advanced prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference—JAPAN 2023;International Journal of Urology;2024-06